Oct 20 (Reuters) - BIOSYNEX SA ALBIO.PA :
* H1 REVENUE EUR 44.1 MILLION
* OBJECTIVE OF €100M IN REVENUES BY 2020
* GROSS OPERATING PROFIT H1 2020: €11.8M
* REVENUE 9 MONTHS 2020: €72.2M (X2.8)
* AT JUNE 30, 2020, GROUP RECORDED CONSOLIDATED
SHAREHOLDERS'
EQUITY OF €41.0 MILLION, AN INCREASE OF 34,3%
* H1 NET RESULT PROFIT EUR 6.2 MILLION VERSUS PROFIT OF EUR
0.6
MILLION YEAR AGO
* AT JUNE 30, 2020, NET DEBT WAS REDUCED TO €1.8 MILLION
VERSUS
€7.5 MILLION AT END OF PREVIOUS FISCAL YEAR (EXCLUDING
RESTATEMENT OF FINANCE LEASES)
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587785110;))